Skip to main content
Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · IEX Real-Time Price · USD
6.03
+0.43 (7.68%)
At close: Apr 26, 2024, 4:00 PM
6.30
+0.27 (4.48%)
After-hours: Apr 26, 2024, 7:49 PM EDT

Health Catalyst Revenue

In the year 2023, Health Catalyst had annual revenue of $295.94M with 7.13% growth. Revenue in the quarter ending December 31, 2023 was $75.08M with 8.56% year-over-year growth.

Revenue (ttm)
$295.94M
Revenue Growth
+7.13%
P/S Ratio
1.19
Revenue / Employee
$227,645
Employees
1,300
Market Cap
353.13M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023295.94M19.70M7.13%
Dec 31, 2022276.24M34.31M14.18%
Dec 31, 2021241.93M53.08M28.11%
Dec 31, 2020188.85M33.90M21.88%
Dec 31, 2019154.94M42.37M37.63%
Dec 31, 2018112.57M39.49M54.04%
Dec 31, 201773.08M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Amarin Corporation 306.91M
Tactile Systems Technology 274.42M
Revance Therapeutics 234.04M
Mersana Therapeutics 36.86M
Precigen 6.23M
Immutep 4.58M
Sera Prognostics 306.00K
Revenue Rankings

HCAT News

More News